CRISPR/Cas9 was first harnessed in 2012 as a genome editing tool in the lab. More recently, scientists have begun to make breakthroughs in the developments of new therapeutic treatment options for patients with chronic illnesses. Even though no treatments have yet to be approved as marketed products, several are in clinical trials.